| 4,5,6,7-Tetrabromobenzotriazole | IC50 | 60.0 [1], 900.0 [2], 1000.0 [3], 1240.0 [4] |
| 4,5,6,7-Tetrabromobenzotriazole | Ki | 2700.0 [1] |
| Silmitasertib | IC50 | 1.0 [1], 3.7 [2], 100.0 [3] |
| Silmitasertib | Ki | 0.38 [1] |
| 4,5,6,7-Tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine | IC50 | 1780.0 [1], 3300.0 [2], 5790.0 [3] |
| 4,5,6,7-Tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine | Ki | 40.0 [1] |
| Quercetin | IC50 | 550.0 [1], 1000.0 [2], 5600.0 [3] |
| Emodin | IC50 | 580.0 [1], 1000.0 [2], 2000.0 [3] |
| (5-Oxo-5,6-dihydro-indolo[1,2-A]quinazolin-7-YL)-acetic acid | IC50 | 80.0 [1], 390.0 [2] |
| Staurosporine | IC50 | 3400.0 [1], 100000.0 [2] |
| Apigenin | IC50 | 800.0 [1], 1000.0 [2] |
| Fisetin | IC50 | 350.0 [1], 1000.0 [2] |
| Fisetin | Ki | 170.0 [1] |
| Ellagic acid | IC50 | 40.0 [1] |
| Myricetin | IC50 | 920.0 [1], 1000.0 [2] |
| 4,5,6,7-Tetrabromobenzimidazole | IC50 | 1000.0 [1] |
| 4,5,6,7-Tetrabromobenzimidazole | Ki | 300.0 [1] |
| (2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine | IC50 | 11800.0 [1] |
| 4-Hydroxybenzo[h]quinoline-3-carboxylic acid | IC50 | 1000.0 [1] |
| 4-Hydroxybenzo[h]quinoline-3-carboxylic acid | Ki | 280.0 [1] |
| 3-[[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol | IC50 | 10000.0 [1] |
| (1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamine | IC50 | 50000.0 [1] |
| 3-{[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}benzoic acid | IC50 | 10.0 [1] |
| 3-{[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}benzoic acid | Ki | 4.5 [1] |
| 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-7-carboxylic acid | IC50 | 500.0 [1] |
| 5-(3-Chloroanilino)benzo[c][2,6]naphthyridine-9-carboxylic acid | IC50 | 350.0 [1] |
| Methyl 5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylate | IC50 | 500.0 [1] |
| N-(3-Chlorophenyl)benzo[c][2,6]naphthyridin-5-amine | IC50 | 500.0 [1] |
| 5-(3-Chloroanilino)benzo[c][2,6]naphthyridine-8-carboxamide | IC50 | 417.0 [1] |
| 5-(3-Chloroanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 7.0 [1], 70.0 [2] |
| 3-[(5-Phenylthieno[2,3-d]pyrimidin-4-yl)amino]benzoic acid | IC50 | 65.0 [1] |
| 3-[(5-Phenylthieno[2,3-d]pyrimidin-4-yl)amino]benzoic acid | Ki | 12.7 [1] |
| 5,6,8-Trichloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | IC50 | 300.0 [1] |
| 5,6,8-Trichloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | Ki | 60.0 [1] |
| 3-[(6-Methyl-5-phenylthieno[2,3-d]pyrimidin-4-yl)amino]benzoic acid | IC50 | 8.0 [1] |
| 3-[(6-Methyl-5-phenylthieno[2,3-d]pyrimidin-4-yl)amino]benzoic acid | Ki | 4.0 [1] |
| [3-Amino-6,7-dichloro-4-cyano-2-(3-methylbut-2-enoyl)-1-benzofuran-5-yl] acetate | IC50 | 200.0 [1] |
| 3-Amino-6,7-dichloro-5-hydroxy-2-(3-methylbut-2-enoyl)-1-benzofuran-4-carbonitrile | IC50 | 200.0 [1] |
| Ethyl 5-acetyloxy-3-amino-6,7-dichloro-4-cyano-1-benzofuran-2-carboxylate | IC50 | 2400.0 [1] |
| 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | IC50 | 6900.0 [1] |
| Kaempferol | IC50 | 1000.0 [1] |
| Luteolin | IC50 | 1000.0 [1] |
| N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | Ki | 136700.0 [1] |
| Morin | IC50 | 10000.0 [1] |
| 9H-Pyrido[3,4-B]indole | IC50 | 25000.0 [1] |
| 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole | Ki | 23000.0 [1] |
| N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide | Ki | 950000.0 [1] |
| 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | IC50 | 100000.0 [1] |
| Danusertib | IC50 | 10000.0 [1] |
| 5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione | IC50 | 20.0 [1] |
| Quinalizarin | Ki | 60.0 [1] |
| Entrectinib | IC50 | 10000.0 [1] |
| N-(6-Chloro-9h-pyrido[3,4-b]indol-8-yl)-3-pyridinecarboxamide | IC50 | 25000.0 [1] |
| 4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamide | IC50 | 100000.0 [1] |
| AS-252424 | IC50 | 20.0 [1] |
| PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 100000.0 [1] |
| A-674563 | Ki | 5400.0 [1] |
| Leucettine L41 | IC50 | 320.0 [1] |
| 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 100000.0 [1] |
| 3-Hydroxy-4'-methoxyflavone | IC50 | 30000.0 [1] |
| 4'-Fluoroflavone | IC50 | 30000.0 [1] |
| 2-(4-(Dimethylamino)phenyl)-3-hydroxy-4H-chromen-4-one | IC50 | 30000.0 [1] |
| JNK Inhibitor VIII | Ki | 5800.0 [1] |
| (E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid | IC50 | 110.0 [1] |
| Cdk1/2 Inhibitor III | IC50 | 100000.0 [1] |
| 4'-Hydroxy-3'-Methoxyflavone | IC50 | 800.0 [1] |
| 3-Hydroxy-3',4'-dimethoxyflavone | IC50 | 30000.0 [1] |
| 5-[(2S)-2-Methylpiperazin-1-yl]sulfonylisoquinoline | Ki | 780000.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| {[5-(4-Bromophenyl)thieno[2,3-d]pyrimidin-4-yl]thio}acetic acid | IC50 | 14000.0 [1] |
| 5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 3.0 [1] |
| Palinurin | IC50 | 100000.0 [1] |
| 3-{[6-(Ethoxycarbonyl)-5-methylthieno[2,3-d]pyrimidin-4-yl]amino}benzoic acid | IC50 | 6500.0 [1] |
| 2-[[(2Z)-2-(Furan-2-ylmethylidene)-3-oxo-1-benzofuran-6-yl]oxy]acetic acid | IC50 | 11000.0 [1] |
| (6-Ethyl-thieno[2,3-d]pyrimidin-4-ylamino)-acetic acid | IC50 | 33000.0 [1] |
| 10-Chlorobenzo[c]quinolizin-11-ium-6-ol | IC50 | 5000.0 [1] |
| (3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-2H-indol-2-one | IC50 | 50000.0 [1] |
| 2-(4-Methoxyphenyl)-4-oxochromen-3-yl acetate | IC50 | 30000.0 [1] |
| 2-({2-[(3-Hydroxyphenyl)amino]pyrimidin-4-YL}amino)benzamide | IC50 | 730.0 [1] |
| 3-(2-Methyl-6-phenylthieno[2,3-d]pyrimidin-4-yl)sulfanylpropanoic acid | IC50 | 3500.0 [1] |
| N-(3-Cyclopropyl-1H-pyrazol-5-YL)-2-(2-naphthyl)acetamide | IC50 | 10000.0 [1] |
| 3-(1,3-Benzodioxol-5-ylmethylene)dihydro-2(3H)-furanone | IC50 | 10000.0 [1] |
| 4H-Naphtho[1,2-b]pyran-4-one, 2-(4-hydroxyphenyl)- | IC50 | 9700.0 [1] |
| 6-Hydroxy-4'-methoxyflavone | IC50 | 30000.0 [1] |
| (5,6-Dimethyl-thieno[2,3-d]pyrimidin-4-ylsulfanyl)-acetic acid | IC50 | 17750.0 [1] |
| (5-Phenyl-thieno[2,3-d]pyrimidin-4-ylsulfanyl)-acetic acid | IC50 | 30000.0 [1] |
| 2-({6-Phenylthieno[2,3-d]pyrimidin-4-yl}sulfanyl)acetic acid | IC50 | 1250.0 [1] |
| 3-Hydroxy-2-(4-methoxyphenyl)-6-methyl-4H-chromen-4-one | IC50 | 28000.0 [1] |
| 2-(5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-ylsulfanyl)propanoic acid | IC50 | 17000.0 [1] |
| 7-Chloro-4-hydroxy-8-methylquinoline-3-carboxylic acid | IC50 | 2000.0 [1] |
| [4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine | Ki | 1000.0 [1] |
| 3-(Cyclopropylamino)-5-{[3-(Trifluoromethyl)phenyl]amino}pyrimido[4,5-C]quinoline-8-Carboxylic Acid | IC50 | 9.0 [1] |
| 2-[1-(4,4-Difluorocyclohexyl)-piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide | IC50 | 10000.0 [1] |
| 2-(4-Nitrophenyl)-4H-chromen-4-one | IC50 | 33700.0 [1] |
| CID 72163809 | IC50 | 2.0 [1] |
| 6-Hydroxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one | IC50 | 26000.0 [1] |
| 4,5,6,7-Tetrabromo-1H,3H-benzimidazol-2-one | Ki | 150.0 [1] |
| ((4,5,6,7-Tetrabromo-1H-benzimidazol-2-yl)sulfanyl)-acetic acid | Ki | 180.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 5800.0 [1] |
| 4-[[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]benzoic acid | IC50 | 650.0 [1] |